mTOR signaling in immune cells and its implications for cancer immunotherapy

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


The realization that cellular metabolism dictates immune cell development, differentiation and function affords metabolic intervention as a potential venue for cancer immunotherapy. mTOR signaling, as a metabolic master regulator, controls immune cell biology in a cell type-specific and context dependent manner. Furthermore, mTOR activity needs to be fine-tuned to maintain proper immune function. These properties may be exploited for therapeutic purpose, yet caution should be taken against radical changes of mTOR activity. Here, the intricate and complex mTOR regulation in different immune cells is reviewed, highlighting latest discoveries and opportunities for cancer immunotherapy.

Original languageEnglish (US)
Pages (from-to)182-189
Number of pages8
JournalCancer Letters
StatePublished - Nov 1 2017


  • Cancer immunotherapy
  • Goldilocks mTOR
  • mTOR-mediated metabolism
  • mTORC1
  • mTORC2

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'mTOR signaling in immune cells and its implications for cancer immunotherapy'. Together they form a unique fingerprint.

Cite this